The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair

Virology

Volumn 422, Issue 1, 2012, Pages 70-80

  Edo Matas, Diana ^a   Rachinger, Andrea ^a   Setiawan, Laurentia C ^a   Boeser Nunnink, Brigitte D ^a   van 't Wout, Angélique B ^a   Lemey, Philippe ^b   Schuitemaker, Hanneke ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

CCR5; Coreceptor use; CXCR4; Envelope; HIV 1; PNGS; R5; Transmission; V3; X4

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DIDANOSINE; INDINAVIR; LAMIVUDINE; STAVUDINE; ZIDOVUDINE;

ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; DONOR SELECTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MOLECULAR EVOLUTION; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; VIRUS CHARACTERIZATION; VIRUS ENVELOPE; VIRUS TRANSMISSION;

AMINO ACID SEQUENCE; EVOLUTION, MOLECULAR; GLYCOSYLATION; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; PEPTIDE FRAGMENTS; PHYLOGENY; RECEPTORS, CCR5; RECEPTORS, CXCR4; SEQUENCE ALIGNMENT; VIRAL ENVELOPE PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 82355180939     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.10.005     Document Type: Article

References (86)

1. Alizon S., et al. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog. 2010, 6.
2. Alkhatib G., et al. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
3. Berson J.A., et al. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic Human Immunodeficiency Virus type 1 strains. J. Virol. 1996, 70:6288-6295.
4. Brieu N., Portales P., Carles M.J., Corbeau P. Interleukin-7 induces HIV type 1 R5-to-X4 switch. Blood 2011, 117:2073-2074.
5. Bunnik E.M., Pisas L., van Nuenen A.C., Schuitemaker H. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J. Virol. 2008, 82:7932-7941.
6. Bunnik E.M., et al. Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level. Nat. Med. 2010, 16:995-997.
7. Cao J., et al. Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. J. Virol. 1997, 71:9808-9812.
8. Casper C.H., et al. Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child. J. Infect. Dis. 2002, 186:914-921.
9. SF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol. 1999, 73:5294-5300.
10. Chesebro B., Wehrly K., Nishio J., Perryman S. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J. Virol. 1996, 70:9055-9059.
11. Connor R.I., Sheridan K.E., Ceradini D., Choe S., Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 1997, 185:621-628.
12. Cordonnier A., Montagnier L., Emerman M. Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature 1989, 340:571-574.
13. Dalgleish A.G., et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312:763-767.
14. De Jong J.J., De Ronde A., Keulen W., Tersmette M., Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 1992, 66:6777-6780.
15. De Roda Husman A.M., van Rij R.P., Blaak H., Broersen S., Schuitemaker H. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for HIV-1 disease progression. J. Infect. Dis. 1999, 180:1106-1115.
16. Deng H.K., et al. Identification of the major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
17. Dragic T., et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
18. Drummond A.J., Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 2007, 7:214.
19. Drummond A.J., Ho S.Y., Phillips M.J., Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol. 2006, 4:e88.
20. Euler Z., et al. Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. J. Infect. Dis. 2010, 201:1045-1053.
21. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
22. Fouchier R.A., et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 1992, 66:3183-3187.
23. Fouchier R.A.M., Brouwer M., Broersen S.M., Schuitemaker H. Simple determination of human immunodeficiency virus type 1 syncytium inducing genotype by PCR. J. Clin. Microbiol. 1995, 33:906-911.
24. Geskus R.B. On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion. Stat. Med. 2000, 19:1753-1769.
25. Goldman N., Yang Z. A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol. Biol. Evol. 1994, 11:725-736.
26. Gras L., et al. Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One 2009, 4:e7365.
27. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41:95-98.
28. Harrowe G., Cheng-Mayer C. Amino acid changes in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 1995, 210:490-494.
29. Hasegawa M., Kishino H., Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J. Mol. Evol. 1985, 22:160-174.
30. Huson D.H., et al. Dendroscope: an interactive viewer for large phylogenetic trees. BMC Bioinformatics 2007, 8:460.
31. Husson R.N., et al. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype. J. Pediatr. 1995, 126:865-871.
32. Jacquez J.A., Koopman J.S., Simon C.P., Longini I.M. Role of the primary infection in epidemics of HIV infection in gay cohorts. J. Acquir. Immune Defic. Syndr. 1994, 7:1169-1184.
33. Jansson M., et al. Sensitivity to inhibition by ß-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:15382-15387.
34. Jansson M., et al. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS. J. Hum. Virol. 1999, 2:325-338.
35. Jensen M.A., et al. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 2003, 77:13376-13388.
36. Ji C., et al. Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activities. Antiviral Res. 2007, 74:125-137.
37. Karlsson A., et al. MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance. J. Infect. Dis. 1994, 170:1367-1375.
38. Karlsson A., Parsmyr K., Sandstrom E., Fenyö E.M., Albert J. MT-2 cell tropism as prognostic marker for disease progression in Human Immunodeficiency Virus type 1 infection. J. Clin. Microbiol. 1994, 32:364-370.
39. Kawashima Y., et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009, 458:641-645.
40. Keele B.F., et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7552-7557.
41. Klatzmann D., et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312:767-768.
42. Koning F.A., et al. Decreasing sensitivity to RANTES neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection. J. Infect. Dis. 2003, 188:864-872.
43. Koopman J.S., et al. The role of early HIV infection in the spread of HIV through populations. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997, 14:249-258.
44. Koot M., et al. HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 1992, 6:49-54.
45. + cell depletion and progression to AIDS. Ann. Intern. Med. 1993, 118:681-688.
46. Koot M., et al. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J. Infect. Dis. 1996, 173:349-354.
47. Koot M., et al. Conversion rate towards a syncytium inducing (SI) phenotype during different stages of HIV-1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis. J. Infect. Dis. 1999, 179:254-258.
48. Kootstra N.A., Schuitemaker H. Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of GAG and Vpr is comparable to wild type HIV-1 in primary macrophages. Virology 1999, 253:170-180.
49. Kosakovsky Pond S.L., Poon A.F.Y., Frost S.D. Estimating selection pressures on alignments of coding sequences. The Phylogenetic Handbook. A Practical Approach to Phylogenetic Analysis and Hypothesis Testing 2009, P. Lemey, M. Salemi, A.M. Vandamme (Eds.).
50. Kuiken C.L., et al. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J. Virol. 1992, 66:4622-4627.
51. Kwa D., Vingerhoed J., Boeser-Nunnink B., Schuitemaker H. Increased in-vitro cytopathicity of CCR5 restricted human immunodeficiency virus type 1 primary isolates correlates with a progressive clinical course of infection. J. Infect. Dis. 2003, 187:1397-1403.
52. Leynaert B., Downs A.M., De Vincenzi I. Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV. Am. J. Epidemiol. 1998, 148:88-96.
53. Minin V.N., Bloomquist E.W., Suchard M.A. Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. Mol. Biol. Evol. 2008, 25:1459-1471.
54. Mosier D.E., et al. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J. Virol. 1999, 73:3544-3550.
55. Pao D., et al. Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 2005, 19:85-90.
56. Pastore C., Ramos A., Mosier D.E. Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching. J. Virol. 2004, 78:7565-7574.
57. Pilcher C.D., et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J. Infect. Dis. 2004, 189:1785-1792.
58. Pond S.L., Frost S.D., Muse S.V. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21:676-679.
59. Posada D., Crandall K.A. Modeltest: testing the model of DNA substitution. Bioinformatics 1998, 14:817-818.
60. Rachinger A., et al. Absence of HIV-1 superinfection 1 year after infection between 1985 and 1997 coincides with a reduction in sexual risk behavior in the seroincident Amsterdam cohort of homosexual men. Clin. Infect. Dis. 2010, 50:1309-1315.
61. Rachinger A., et al. Low incidence of HIV-1 superinfection even after episodes of unsafe sexual behavior of homosexual men in the Amsterdam Cohort Studies on HIV infection and AIDS. J. Infect. Dis. 2011, 203:1621-1628.
62. Repits J., et al. Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency. J. Gen. Virol. 2005, 86:2859-2869.
63. Sagar M., Wu X., Lee S., Overbaugh J. Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J. Virol. 2006, 80:9586-9598.
64. Salazar-Gonzalez J.F., et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 2008, 82:3952-3970.
65. Saunders C.J., et al. The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. J. Virol. 2005, 79:9069-9080.
66. Scarlatti G., et al. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. Virology 1993, 197:624-629.
67. Scarlatti G., et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine mediated suppression. Nat. Med. 1997, 3:1259-1265.
68. Schuitemaker H., et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 1992, 66:1354-1360.
69. Shimizu N., et al. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein. Virology 1999, 259:324-333.
70. Shioda T., Levy J.A., Cheng-Mayer C. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:9434-9438.
71. Sing T., et al. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir. Ther. 2007, 12:1097-1106.
72. Suchard M.A., Kitchen C.M., Sinsheimer J.S., Weiss R.E. Hierarchical phylogenetic models for analyzing multipartite sequence data. Syst. Biol. 2003, 52:649-664.
73. Tersmette M., et al. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV-p24 gag. Virology 1989, 171:149-155.
74. van Gils M.J., et al. Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors. J. Virol. 2010, 84:3576-3585.
75. van Gils M.J., et al. Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies. J. Virol. 2011, 85:6986-6995.
76. van Rij R.P., et al. Early viral load and CD4 T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells are associated with R5 to X4 virus evolution. AIDS Res. Hum. Retroviruses 2003, 19:389-398.
77. Van 't Wout A.B., et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 1994, 94:2060-2067.
78. Van 't Wout A.B., et al. Evolution of syncytium inducing and non-syncytium inducing biological virus clones in relation to replication kinetics during the course of HIV-1 infection. J. Virol. 1998, 72:5099-5107.
79. Van 't Wout A.B., Schuitemaker H., Kootstra N.A. Isolation and propagation of HIV-1 on peripheral blood mononuclear cells. Nat. Protoc. 2008, 3:363-370.
80. van Manen, D., et al. Rising HIV-1 viral load set-point at a population level coincides with a fading impact of host genetic factors on HIV-1 control. AIDS 2011, (Electronic publication ahead of print).
81. Wei X., et al. Antibody neutralization and escape by HIV-1. Nature 2003, 422:307-312.
82. Wilgenbusch J.C., Swofford D. Inferring evolutionary trees with PAUP*. Curr. Protoc. Bioinformatics 2003, Chapter 6, Unit 6.4.
83. Yang Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 1997, 13:555-556.
84. Yang Z. Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. Mol. Biol. Evol. 1998, 15:568-573.
85. Yerly S., et al. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS 2001, 15:2287-2292.
86. Zhang M., et al. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004, 14:1229-1246.